Skip to main content

Table 6 CLART and LA: agreement with HC2

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

Genotyping assay

Assay+/HC2+

Assay+/HC2-

Assay-/HC2+

Assay-/HC2-

401 women with abnormal cytology

    

CLART

301 (75%)

10 (2%)

54 (13%)

36 (9%)

LA

315 (79%)

11 (3%)

40 (10%)

35 (9%)

125 women with ≥ CIN2

    

CLART

116 (93%)

0 (0%)

7 (6%)

2 (2%)

LA

120 (96%)

0 (0%)

3 (2%)

2 (2%)